Norman David Eansor - Aug 6, 2021 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
President-Protein Sciences
Signature
/s/ Brenda S. Furlow as Attorney-in-Fact for N. David Eansor pursuant to Power of Attorney previously filed.
Stock symbol
TECH
Transactions as of
Aug 6, 2021
Transactions value $
-$481,338
Form type
4
Date filed
8/10/2021, 06:19 PM
Previous filing
Jun 10, 2021
Next filing
Sep 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Options Exercise $0 +2.54K +192.49% $0.00 3.86K Aug 8, 2021 Direct
transaction TECH Common Stock Tax liability -$481K -999 -25.91% $481.82 2.86K Aug 8, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Restricted Stock Units Options Exercise $0 -2.54K -100% $0.00* 0 Aug 8, 2021 Common Stock 2.54K Direct F1, F3
transaction TECH Restricted Stock Units Award $0 +1.56K $0.00 1.56K Aug 6, 2021 Common Stock 1.56K Direct F1, F11
transaction TECH Stock Options (Right to Buy) Award $0 +6.08K $0.00 6.08K Aug 6, 2021 Common Stock 6.08K $481.82 Direct F11
transaction TECH Stock Options (Right to Buy) Award $0 +8.11K $0.00 8.11K Aug 6, 2021 Common Stock 8.11K $481.82 Direct F12
holding TECH Stock Options (Right to Buy) 12K Aug 6, 2021 Common Stock 12K $125.05 Direct F2
holding TECH Stock Options (Right to Buy) 16K Aug 6, 2021 Common Stock 16K $125.05 Direct F2
holding TECH Stock Options (Right to Buy) 13.6K Aug 6, 2021 Common Stock 13.6K $177.32 Direct F3
holding TECH Stock Options (Right to Buy) 18.1K Aug 6, 2021 Common Stock 18.1K $177.32 Direct F4
holding TECH Restricted Stock Units 3.15K Aug 6, 2021 Common Stock 3.15K Direct F1, F5
holding TECH Stock Options (Right to Buy) 15.9K Aug 6, 2021 Common Stock 15.9K $190.41 Direct F5
holding TECH Stock Options (Right to Buy) 21.3K Aug 6, 2021 Common Stock 21.3K $190.41 Direct F6
holding TECH Restricted Stock Units 2.58K Aug 6, 2021 Common Stock 2.58K Direct F1, F7
holding TECH Stock Options (Right to Buy) 11.5K Aug 6, 2021 Common Stock 11.5K $267.87 Direct F7
holding TECH Stock Options (Right to Buy) 15.3K Aug 6, 2021 Common Stock 15.3K $267.87 Direct F8
holding TECH Stock Options (Right to Buy) 25K Aug 6, 2021 Common Stock 25K $267.87 Direct F9
holding TECH Stock Options (Right to Buy) 25K Aug 6, 2021 Common Stock 25K $267.87 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F2 Fully exercisable.
F3 Vested in full on 8/8/2021 upon the certification of achievement of performance goals.
F4 Options to purchase 4,517 shares vest on each of 8/8/2019 and 8/8/2020 and options to purchase 4,516 shares vest on each of 8/8/2021 and 8/8/2022.
F5 Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F6 Options to purchase 5,317 shares vest on 8/7/2020 and options to purchase 5,316 shares vest on each of 8/7/2021, 8/7/2022 and 8/7/2023.
F7 Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F8 Options to purchase 3,830 shares vest on each of 8/5/2021 and 8/5/2022 and options to purchase 3,829 shares vest on each of 8/5/2023 and 8/5/2024.
F9 Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
F10 Options to purchase 8,325 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
F11 Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F12 Options to purchase 2,027 shares vest on each of 8/6/2022, 8/6/2023 and 8/6/2024 and options to purchase 2,026 shares vest on 8/6/2025.